SCHEMBL8607286

SCHEMBL8607286

NS(=O)(=O)c1ccccc1-c1oc(CNC(=O)NO)nc1-c1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.40
PTGS2 P35354 3/20 0.40
CA9 Q16790 1/20 0.39
NR4A2 P43354 6/20 0.39
NAMPT P43490 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
RXRA P19793 4/20 0.37
MAPT P10636 1/20 0.37
RXRB P28702 3/20 0.36
RXRG P48443 1/20 0.36
SCN9A Q15858 2/20 0.36
USP1 O94782 1/20 0.35
USP19 O94966 1/20 0.35
UCHL3 P15374 1/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8604310 0.90 RXRA (0.43) CA9NR4A2NAMPTRXRARXRB
SCHEMBL6860700 0.90 PTGS1 (0.41) PTGS1PTGS2CA9NR4A2TRPV1
SCHEMBL8604021 0.87 PTGS1 (0.41) PTGS1PTGS2CA9NR4A2RXRA
SCHEMBL6308687 0.87 NR4A2 (0.44) PTGS1PTGS2CA9NR4A2TRPV1
SCHEMBL8607283 0.84 PTGS2 (0.57) PTGS1PTGS2CA9NR4A2
SCHEMBL8556142 0.83 PTGS2 (0.46) PTGS1PTGS2CA9NR4A2TRPV1
SCHEMBL8605986 0.82 RXRA (0.43) CA9NR4A2NAMPTRXRARXRB
SCHEMBL8606455 0.82 NR4A2 (0.47) PTGS1PTGS2NR4A2RXRARXRB
SCHEMBL8558402 0.81 PTGS2 (0.44) PTGS1PTGS2NR4A2TRPV1RXRA
SCHEMBL8604402 0.81 PTGS2 (0.43) PTGS1PTGS2NR4A2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828718-A1 HETEROCYCLO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS CYCLOOXYGENASE-2 AND 5-LIPOXYGENASE INHIBITORS G.D. SEARLE & CO. (US) 1998-03-18 EP disclosed
WO-1996038418-A1 HETEROCYCLO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS CYCLOOXYGENASE-2 AND 5-LIPOXYGENASE INHIBITORS G.D. SEARLE & CO. (US) 1996-12-05 WO disclosed